Indications
Treatment of the symptoms (increased urinary frequency and / or urgency and / or urgency incontinence) that may occur in patients with overactive-bladder syndrome.
Composition
- Active substance
- fesoterodine fumarate
- International name (INN)
- fesoterodine
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Toviaz
- Active substance
- fesoterodine fumarate
- ATC code
- G04BD11
- Therapeutic area
- Urinary Bladder, Overactive
- Marketing authorisation holder
- Pfizer Europe MA EEIG